Compare Stocks

→ He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADVM Adverum Biotechnologies	$11.00 -3.0%	$16.04	$7.10 ▼ $29.70	$235.36M	0.84	198,919 shs	304,948 shs
ATMS Artemis Therapeutics	$0.05	$0.07	$0.11 ▼ $5.00	$5.60M	-1.92	2,942 shs	20 shs
MRIC MRI Interventions		$5.14	$2.01 ▼ $6.28	$78.16M	N/A	63,036 shs	51,600 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADVM Adverum Biotechnologies	-3.00%	-5.25%	-31.51%	+21.01%	+21.95%
ATMS Artemis Therapeutics	0.00%	0.00%	-10.71%	-29.68%	-83.27%
MRIC MRI Interventions	0.00%	0.00%	0.00%	0.00%	0.00%

He Is Giving Away Bitcoin (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADVM Adverum Biotechnologies	4.055 of 5 stars	3.5	2.0	0.0	4.8	3.1	2.5	0.0
ATMS Artemis Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MRIC MRI Interventions	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADVM Adverum Biotechnologies	3.00	Buy	$34.67	215.15% Upside
ATMS Artemis Therapeutics	N/A	N/A	N/A	N/A
MRIC MRI Interventions	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest MRIC, ATMS, and ADVM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/19/2024	ADVM Adverum Biotechnologies	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$4.00
2/6/2024	ADVM Adverum Biotechnologies	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $40.00

(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADVM Adverum Biotechnologies	$3.60M	63.40	N/A	N/A	$8.26 per share	1.33
ATMS Artemis Therapeutics	$310K	18.07	N/A	N/A	($0.01) per share	-5.00
MRIC MRI Interventions	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADVM Adverum Biotechnologies	-$117.17M	-$11.60	N/A	N/A	N/A	N/A	-98.65%	-52.85%	5/9/2024 (Estimated)
ATMS Artemis Therapeutics	-$1.36M	N/A	0.00	∞	N/A	-299.54%	N/A	-425.51%	N/A
MRIC MRI Interventions	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Latest MRIC, ATMS, and ADVM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/18/2024	Q4 2023	ADVM Adverum Biotechnologies	-$2.80	-$2.30	+$0.50	-$2.30	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADVM Adverum Biotechnologies	N/A	N/A	N/A	N/A	N/A
ATMS Artemis Therapeutics	N/A	N/A	N/A	N/A	N/A
MRIC MRI Interventions	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADVM Adverum Biotechnologies	N/A	4.13	4.13
ATMS Artemis Therapeutics	N/A	0.15	0.12
MRIC MRI Interventions	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ADVM Adverum Biotechnologies	48.17%
ATMS Artemis Therapeutics	N/A
MRIC MRI Interventions	N/A

Insider Ownership

Company	Insider Ownership
ADVM Adverum Biotechnologies	5.30%
ATMS Artemis Therapeutics	7.45%
MRIC MRI Interventions	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ADVM Adverum Biotechnologies	121	20.75 million	19.66 million	Optionable
ATMS Artemis Therapeutics	1	112.03 million	103.69 million	Not Optionable
MRIC MRI Interventions	38	15.21 million	N/A	Not Optionable

MRIC, ATMS, and ADVM Headlines

Source	Headline
	Orkney mobile MRI scanner service extended orcadian.co.uk - April 24 at 8:26 AM
	Nationals' Lane Thomas: Getting MRI on knee cbssports.com - April 24 at 3:26 AM
	Good chances for health insurance MRI in Mistelbach and Horn krone.at - April 24 at 3:26 AM
	Triston Casas' MRI Confirms Serious Injury msn.com - April 23 at 5:25 PM
	3 Triston Casas replacements Red Sox need to consider after MRI delivers bad news msn.com - April 23 at 5:25 PM
	Red Sox's Triston Casas: MRI confirms significant injury cbssports.com - April 23 at 7:23 AM
	MRI scanner inventor honoured with hospital plaque news.yahoo.com - April 23 at 7:23 AM
	Sewald to Begin Rehab Assignment, Kelly to Get Second MRI on Shoulder si.com - April 22 at 9:22 PM
	Diamondbacks’ Merrill Kelly receiving a second MRI on shoulder injury isn’t a good sign msn.com - April 22 at 9:22 PM
	iRadimed resumed at Roth MKM as a buy as only provider of MRI-compatible IV pumps msn.com - April 22 at 2:16 PM
	Rockies' Noah Davis: Scheduled for MRI cbssports.com - April 22 at 2:16 PM
	Shaun Livingston's MRI OK, but Warriors say return uncertain msn.com - April 22 at 2:16 PM
	CMC Vellore introduces state-of-the-art AI-powered MRI scanner medicaldialogues.in - April 22 at 9:15 AM
	NFF mandates pre-camp MRI test for Eaglets punchng.com - April 22 at 12:29 AM
	Francisco Alvarez Going For MRI On His Thumb msn.com - April 20 at 2:18 PM
	Rafael Devers Will Undergo MRI On Knee msn.com - April 20 at 9:18 AM
	Mets' Francisco Alvarez: Undergoing MRI on thumb cbssports.com - April 20 at 9:18 AM
	CMC Vellore becomes first hospital in country to have state-of-the-art AI-powered MRI scanner health.economictimes.indiatimes.com - April 20 at 9:18 AM
	Blue Jays' Ricky Tiedemann: Undergoes MRI for elbow injury cbssports.com - April 19 at 7:37 PM
	New MRI ready and raring from Monday wangarattachronicle.com.au - April 19 at 7:37 PM
	Toronto Blue Jays Holding Their Breath as Top Prospect Goes Elbow MRI si.com - April 19 at 7:37 PM
	MRI improvements at Sylacauga business make experience more comfortable for patients annistonstar.com - April 19 at 2:37 PM
	PCMC's new MRI, CT scanners boost health services for Filipino kids pna.gov.ph - April 19 at 9:36 AM
	Red Sox's Rafael Devers: Needs MRI on knee cbssports.com - April 19 at 4:36 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Adverum Biotechnologies

NASDAQ:ADVM

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients with wet age-related macular degeneration and diabetic macular edema which is in phase 2 clinical trials. The company is developing ADVM-062 (AAV.7m8-L-opsin), a novel gene therapy product candidate for the treatment of blue cone monochromacy via a single IVT injection. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Artemis Therapeutics

OTCMKTS:ATMS

Artemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.

MRI Interventions

OTCMKTS:MRIC

MRI Interventions, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging guidance. It offers ClearPoint system, a neuro-navigation system designed for placing catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. The company has a strategic agreement with Voyager Therapeutics, Inc. for the neurosurgical device service, supply, and development; and a collaborative license and co-development agreement with Clinical Laserthermia Systems AB to provide navigation and laser ablation platforms for use in spine and neurosurgery. MRI Interventions, Inc. was founded in 1998 and is headquartered in Irvine, California.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial